NCT04781751

Brief Summary

Insulin injection in carpal tunnel compared with dexamethsone in diabetic patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

February 28, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2021

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
Last Updated

March 4, 2021

Status Verified

March 1, 2021

Enrollment Period

1 month

First QC Date

February 24, 2021

Last Update Submit

March 1, 2021

Conditions

Pain, Neuropathic

Outcome Measures

Primary Outcomes (1)

  • pain relief

    consumption analgesics

    12 weeks

Study Arms (2)

dexamethasone

NO INTERVENTION

dexamethasone with local anesthetics injected for carpal tunnel relief

Insulin group

ACTIVE COMPARATOR

insulin with local anesthetics and dexamehtasone injected for carpal tunnel relief

Drug: insulin injection

Interventions

insulin injectionDRUG

Carpal tunnel syndrome sonagraphic injection

Insulin group

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All diabetic patients with carpal tunnel syndrome

You may not qualify if:

  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minia University

ALMinya, 6115, Egypt

RECRUITING

MeSH Terms

Conditions

Neuralgia

Interventions

Insulin

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ProinsulinInsulinsPancreatic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia and ICU

Study Record Dates

First Submitted

February 24, 2021

First Posted

March 4, 2021

Study Start

February 28, 2021

Primary Completion

April 5, 2021

Study Completion

April 30, 2021

Last Updated

March 4, 2021

Record last verified: 2021-03

Locations

EG(1)